Revolution Medicines · 11 hours ago
Associate Director, Independent Medical Education (IME) & Grants
United States
Full-time
Remote
Senior Level, Lead/Staff, Director/Executive
$186K/yr - $233K/yr
7+ years expRevolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The Associate Director, Independent Medical Education (IME) & Grants will oversee and execute IME programs and grants processes, ensuring scientific rigor and compliance while collaborating with internal and external stakeholders.
Health CareLife ScienceMedical
Responsibilities
Facilitate ongoing implementation of a comprehensive IME/CME strategy aligned with Revolution Medicines' scientific and educational priorities
Review IME grant proposals for scientific accuracy, instructional design, and alignment with adult learning principles and therapeutic area needs
Maintain compliant partnerships with medical education providers, professional societies, and academic institutions to support high-quality educational programs
Monitor educational gaps, learning objectives, and emerging scientific trends to ensure content relevance and impact
Audit and evaluate the effectiveness of IME/CME programs, aggregating outcomes and reporting insights and impact to internal stakeholders
Adhere to the governance structure for reviewing, funding, and tracking grants, ensuring transparency and compliance with applicable guidelines (e.g., ACCME, PhRMA Code, FDA, and OIG)
Develop familiarity and fluency with operational needs of the function, including the grants management portal and the contracting and payments process
Work cross-functionally with Compliance, Legal, and Finance teams to ensure appropriate documentation, reporting, and audit readiness for medical grants
Ensure timely and transparent communication with grant recipients regarding receipt and review of submitted requests, maintaining strong external partnerships
Collaborate closely with Director, IME & Grants, to communicate educational funding decisions, newly launched programs, and interim and final outcomes to appropriate internal stakeholders
Foster relationships with external medical and scientific communities, including medical societies, KOLs, academic researchers, and educational providers
Qualification
Required
Advanced scientific or medical degree (PhD, PharmD, MD) preferred; MS or equivalent experience in biomedical sciences or related field considered
7 to 9 years of experience in Medical Affairs, Independent Medical Education, and/or Grants Management, within the biotechnology, pharmaceutical or related industry
Understanding of IME/CME regulations, industry guidelines, and best practices (ACCME, PhRMA Code, FDA, OIG, AdvaMed, Sunshine Act)
Proven ability to work independently and develop medical education strategies aligned with scientific priorities and unmet educational needs
Strong expertise in grants governance, funding oversight, and compliance frameworks
Ability to navigate cross-functional partnerships with Legal, Compliance, Regulatory, and Clinical teams
Strong analytical and strategic thinking skills with competence to assess educational proposals for scientific merit and alignment
Excellent organizational, interpersonal, communication and presentation skills to engage internal and external stakeholders effectively
Willingness to travel within the US and globally, as needed
Preferred
Prior launch experience in oncology, precision medicine, or targeted therapies
Demonstrable patient-centric approach to work in previous roles
Familiarity with digital tools and platforms for grant submissions and tracking
Ability to optimize IME & grants processes for scalability and operational efficiency
Benefits
Competitive cash compensation
Robust equity awards
Strong benefits
Significant learning and development opportunities
Company
Revolution Medicines
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$2.25BKey Investors
Royalty PharmaBoxer CapitalNextech Invest
2025-06-24Post Ipo Debt· $250M
2024-12-02Post Ipo Equity· $750M
2023-03-02Post Ipo Equity· $323.6M
Leadership Team
Luan Wilfong
Chief Human Resources Officer
Steve Kelsey
President
Recent News
Pharmaceutical Technology
2026-01-13
Company data provided by crunchbase